Zobrazeno 1 - 10 of 102 pro vyhledávání: '"Keen Hun, Tai"'
1
Akademický článek
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up
Autor: Ciara Conduit, Thuan Tzen Koh, Michael S Hofman, Guy C Toner, Jeremy Goad, Nathan Lawrentschuk, Keen-Hun Tai, Jeremy H Lewin, Ben Tran
Publikováno v: Cancer Imaging, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Survivors of testicular cancer may experience long-term morbidity following treatment. There is an unmet need to investigate techniques that can differentiate individuals who need additional therapy from those who do not. 2-18fluo
Externí odkaz: https://doaj.org/article/0eeadf1443534cc485a6cb545978a500
Zobrazit plný text záznamu
2
Akademický článek
A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer
Autor: Janice Yeh, Mathias Bressel, Keen Hun Tai, Tomas Kron, Farshad Foroudi
Publikováno v: Clinical and Translational Radiation Oncology, Vol 30, Iss , Pp 65-70 (2021)
Background and Purpose: To report long-term outcomes of online image-guided (IG) adaptive radiation therapy (aRT) versus conventional IG radiation therapy (cRT) for bladder preservation in muscle-invasive bladder cancer (MIBC). Materials and Methods:
Externí odkaz: https://doaj.org/article/e3cfeebcbde04bc3901ba300b0b5f5ec
Zobrazit plný text záznamu
3
The dosimetric error due to uncorrected tumor rotation during real‐time adaptive prostate stereotactic body radiation therapy
Autor: Chandrima Sengupta, Simon Skouboe, Thomas Ravkilde, Per Rugaard Poulsen, Doan Trang Nguyen, Peter B. Greer, Trevor Moodie, Nicholas Hardcastle, Amy J. Hayden, Sandra Turner, Shankar Siva, Keen‐Hun Tai, Jarad Martin, Jeremy T. Booth, Ricky O'Brien, Paul J. Keall
Publikováno v: Sengupta, C, Skouboe, S, Ravkilde, T, Poulsen, P R, Nguyen, D T, Greer, P B, Moodie, T, Hardcastle, N, Hayden, A J, Turner, S, Siva, S, Tai, K H, Martin, J, Booth, J T, O'Brien, R & Keall, P J 2023, ' The dosimetric error due to uncorrected tumor rotation during real-time adaptive prostate stereotactic body radiation therapy ', Medical Physics, vol. 50, no. 1, pp. 20-29 . https://doi.org/10.1002/mp.16094
Background: During prostate stereotactic body radiation therapy (SBRT), prostate tumor translational motion may deteriorate the planned dose distribution. Most of the major advances in motion management to date have focused on correcting this one asp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d8cd972411f1fbd591bd403e1a1b7b2
https://doi.org/10.1002/mp.16094
Zobrazit plný text záznamu
4
Akademický článek
Support for the use of objective comorbidity indices in the assessment of noncancer death risk in prostate cancer patients
Autor: Sweet Ping Ng, Gillian Duchesne, Keen-Hun Tai, Farshad Foroudi, Gargi Kothari, Scott Williams
Publikováno v: Prostate International, Vol 5, Iss 1, Pp 8-12 (2017)
Background: Prostate cancer management involves a balance between the risks of cancer death against those from other causes. To evaluate the performance of several comorbidity indices in predicting comorbid death in a prostate cancer radiotherapy coh
Externí odkaz: https://doaj.org/article/7103db9d335b4cb585bd00f6231e1758
Zobrazit plný text záznamu
5
Akademický článek
TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol
Autor: Colin I Tang, Christopher Oldmeadow, Jeremy Millar, Jarad Martin, Paul Keall, Shankar Siva, Peter Greer, David Christie, Kevin Moore, Jason Dowling, David Pryor, Peter Chong, Nicholas McLeod, Avi Raman, James Lynam, Joanne Smart, Declan G Murphy, Keen Hun Tai, Lois Holloway, Penny Reeves, Amy Hayden, Tee Lim, Tanya Holt, Mark Sidhom
Publikováno v: BMJ Open, Vol 9, Iss 8 (2019)
Introduction Stereotactic body radiotherapy (SBRT) is a non-invasive alternative to surgery for the treatment of non-metastatic prostate cancer (PC). The objectives of the Novel Integration of New prostate radiation schedules with adJuvant Androgen d
Externí odkaz: https://doaj.org/article/e79f4f8788cf40b08288a3571ae571e3
Zobrazit plný text záznamu
6
Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial
Autor: Andrew Kneebone, Sandra Turner, George Hruby, Thomas Eade, Jeremy T. Booth, Keen Hun Tai, Amy Hayden, Paul J. Keall, Ricky O'Brien, Doan Trang Nguyen, Shankar Siva, Per Rugaard Poulsen, Peter B. Greer, Jarad Martin, Trevor Moodie, Nicholas Hardcastle, Emily A. Hewson
Publikováno v: Hewson, E A, Nguyen, D T, O'Brien, R, Poulsen, P R, Booth, J T, Greer, P, Eade, T, Kneebone, A, Hruby, G, Moodie, T, Hayden, A J, Turner, S L, Hardcastle, N, Siva, S, Tai, K H, Martin, J & Keall, P J 2020, ' Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial ', Radiotherapy and Oncology, vol. 151, pp. 234-241 . https://doi.org/10.1016/j.radonc.2020.08.010
Radiotherapy & Oncology
PurposeStereotactic Ablative Radiotherapy (SABR) has recently emerged as a favourable treatment option for prostate cancer patients. With higher doses delivered over fewer fractions, motion adaptation is a requirement for accurate delivery of SABR. T
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c24802a364f25da5722e721cb8d354e2
https://doi.org/10.1016/j.radonc.2020.08.010
Zobrazit plný text záznamu
8
Akademický článek
Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial
Autor: Allison Steigler, James W. Denham, David S. Lamb, Nigel A. Spry, David Joseph, John Matthews, Chris Atkinson, Sandra Turner, John North, David Christie, Keen-Hun Tai, Chris Wynne
Publikováno v: Prostate Cancer, Vol 2012 (2012)
Purpose. Survival following biochemical failure is highly variable. Using a randomized trial dataset, we sought to define a risk stratification scheme in men with locally advanced prostate cancer (LAPC). Methods. The TROG 96.01 trial randomized 802 m
Externí odkaz: https://doaj.org/article/9c071dafa4314d1ebda5d31083faa934
Zobrazit plný text záznamu
9
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
Autor: Nathan Lawrentschuk, Michael S Hofman, Andrew Lim, Daniel Moon, Cristian Udovicich, Keen Hun Tai, Declan G. Murphy, Mathias Bressel, Mark Shaw, Shankar Siva, Jeremy Goad, Lisa Selbie, John Violet, Sarat Chander, Farshad Foroudi, Tomas Kron
Publikováno v: European Urology. 74:455-462
Background Stereotactic ablative body radiotherapy (SABR) is an emerging treatment option for oligometastatic prostate cancer. However, limited prospective evidence is available. Objective To determine the safety and feasibility of single fraction SA
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ed7baf96348ce887d49b4f94321c7cec
https://doi.org/10.1016/j.eururo.2018.06.004
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje